Abstract
The aim of this work was to study the anti-Candida activity of lidocaine and nitroglycerin alone and in combination. Ten Candida strains were included, corresponding to 1 collection type strain (ATCC 10231) and 9 clinical isolates: 4 C. albicans, 2 C. glabrata, 1 C. tropicalis, 1 C. krusei, and 1 C. parapsilosis. The CLSI reference M27-A3 micromethod was used to determine the anti-Candida activity of the drugs alone; minimal inhibitory and lethal concentrations were determined. The classic checkboard technique was used to determine the activity of combined drugs. Lidocaine fungicidal effect was dosedependent. Nitroglycerin exhibited a higher effect. The drugs combination resulted in a reduction of the inhibitory concentration, corresponding to an additive effect. In conclusion, both drugs exhibited an interesting anti-Candida activity. The combination of lidocaine with nitroglycerin was shown to have an additive effect against Candida spp., predicting the interest to include, in the future, these drugs in a new delivery system for the treatment of mucocutaneous candidosis.
Links
Authors
Palmeira-de-Oliveira A, Ramos AR, Gaspar C, Palmeira-de-Oliveira R, Gouveia P, Martinez-de-Oliveira J
Institution
Health Sciences Research Center, Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal. apo@fcsaude.ubi.pt
Source
Infectious diseases in obstetrics and gynecology 2012: 2012 pg 727248MeSH
Antifungal AgentsCandida
Drug Therapy, Combination
Lidocaine
Microbial Sensitivity Tests
Nitroglycerin
Pub Type(s)
Journal ArticleLanguage
eng
PubMed ID
22675243
Log In

